| XBI SS SPDR S&P Biotech ETF | 48.01% | 570,000 | $90.2M | Add +100.1% |
| SGOV iShares 0-3 Month Treasury B | 37.51% | 700,000 | $70.5M | No change |
| RPRX Royalty Pharma PLC Class A | 0.33% | 11,000 | $617K | No change |
| NRIX Nurix Therapeutics Inc. | 0.32% | 25,000 | $607K | Reduce -12.9% |
| INCY Incyte Corp. | 0.32% | 5,300 | $601K | No change |
| ARGX Argenx SE - ADR | 0.32% | 641 | $595K | No change |
| IRON Disc Medicine Inc. | 0.31% | 8,000 | $585K | No change |
| RAPP Rapport Therapeutics Inc. | 0.31% | 14,000 | $583K | No change |
| RARE Ultragenyx Pharmaceutical Inc. | 0.30% | 17,000 | $568K | Reduce -23.1% |
| TRVI Trevi Therapeutics Inc. | 0.30% | 30,000 | $560K | No change |
| GLUE Monte Rosa Therapeutics Inc. | 0.30% | 23,000 | $557K | Reduce -17.9% |
| TGTX TG Therapeutics Inc. | 0.29% | 10,000 | $549K | Reduce -23.1% |
| HALO Halozyme Therapeutics Inc. | 0.29% | 7,000 | $548K | Reduce -12.8% |
| IONS Ionis Pharmaceuticals Inc. | 0.29% | 6,800 | $539K | No change |
| PHVS Pharvaris NV | 0.28% | 15,000 | $519K | Reduce -25.0% |
| ARQT Arcutis Biotherapeutics Inc. | 0.27% | 19,700 | $517K | No change |
| AUPH Aurinia Pharmaceuticals Inc. | 0.27% | 30,000 | $509K | No change |
| NBIX Neurocrine Biosciences Inc. | 0.27% | 3,000 | $506K | Reduce -22.0% |
| IMVT Immunovant Inc. | 0.27% | 13,000 | $501K | Reduce -32.3% |
| ACAD Acadia Pharmaceuticals Inc. | 0.27% | 19,766 | $500K | No change |
| PTCT PTC Therapeutics Inc. | 0.26% | 6,000 | $489K | No change |
| CLDX Celldex Therapeutics Inc. | 0.26% | 13,000 | $484K | No change |
| IMCR Immunocore Holdings PLC-ADR | 0.26% | 15,141 | $481K | No change |
| DFTX Definium Therapeutics Inc. | 0.25% | 10,000 | $470K | Reduce -71.3% |
| COGT Cogent Biosciences Inc. | 0.25% | 12,000 | $464K | No change |
| KYMR Kymera Therapeutics Inc. | 0.24% | 4,000 | $459K | Reduce -36.5% |
| DYN Dyne Therapeutics Inc. | 0.24% | 20,000 | $444K | No change |
| ALNY Alnylam Pharmaceuticals Inc. | 0.23% | 1,465 | $441K | No change |
| TARS Tarsus Pharmaceuticals Inc. | 0.23% | 7,000 | $441K | No change |
| SNDX Syndax Pharmaceuticals Inc. | 0.23% | 20,000 | $437K | No change |
| EXEL Exelixis Inc. | 0.23% | 8,000 | $435K | Reduce -33.0% |
| CRNX Crinetics Pharmaceuticals Inc. | 0.22% | 11,000 | $412K | No change |
| NAMS Newamsterdam Pharma Co. NV | 0.22% | 12,000 | $407K | Reduce -20.0% |
| ASND Ascendis Pharma A/S | 0.21% | 1,500 | $400K | Reduce -40.0% |
| LQDA Liquidia Corp. | 0.21% | 5,000 | $399K | New |
| STOK Stoke Therapeutics Inc. | 0.21% | 12,000 | $393K | No change |
| VKTX Viking Therapeutics Inc. | 0.21% | 10,000 | $390K | Reduce -33.3% |
| IMNM Immunome Inc. | 0.20% | 18,000 | $381K | Reduce -10.0% |
| PTGX Protagonist Therapeutics Inc. | 0.20% | 3,000 | $368K | No change |
| HRMY Harmony Biosciences Holdings | 0.19% | 10,000 | $364K | Reduce -30.0% |
| ELVN Enliven Therapeutics Inc. | 0.19% | 7,000 | $355K | No change |
| SYRE Spyre Therapeutics Inc. | 0.19% | 4,000 | $355K | Reduce -22.5% |
| NTLA Intellia Therapeutics Inc. | 0.18% | 20,000 | $338K | Reduce -25.6% |
| MDGL Madrigal Pharmaceuticals Inc. | 0.17% | 600 | $322K | No change |
| KNSA Kiniksa Pharmaceuticals Inte | 0.17% | 5,000 | $320K | Reduce -44.4% |
| ALKS Alkermes PLC | 0.17% | 6,000 | $314K | No change |
| TNGX Tango Therapeutics Inc. | 0.17% | 10,000 | $313K | Reduce -30.6% |
| ARDX Ardelyx Inc. | 0.16% | 60,000 | $306K | Reduce -25.0% |
| VERA Vera Therapeutics Inc. | 0.16% | 7,000 | $300K | Reduce -30.0% |
| MIRM Mirum Pharmaceuticals Inc. | 0.16% | 2,500 | $293K | Reduce -50.0% |
| ORKA Oruka Therapeutics Inc. | 0.15% | 3,000 | $286K | Reduce -39.6% |
| SUPN Supernus Pharmaceuticals Inc. | 0.15% | 6,000 | $279K | No change |
| CRSP Crispr Therapeutics AG | 0.15% | 5,000 | $273K | Reduce -47.4% |
| ZYME Zymeworks Inc. | 0.14% | 10,000 | $261K | No change |
| KRYS Krystal Biotech Inc. | 0.14% | 692 | $257K | New |
| CMPS Compass Pathways PLC | 0.14% | 18,000 | $255K | Reduce -74.7% |
| XENE Xenon Pharmaceuticals Inc. | 0.13% | 4,200 | $254K | No change |
| AXSM Axsome Therapeutics Inc. | 0.13% | 1,000 | $245K | Reduce -64.8% |
| AVBP Arrivent Biopharma Inc. | 0.13% | 7,041 | $245K | New |
| DNTH Dianthus Therapeutics Inc. | 0.13% | 2,500 | $244K | Reduce -50.0% |
| JAZZ Jazz Pharmaceuticals PLC | 0.12% | 971 | $234K | New |
| KOD Kodiak Sciences Inc. | 0.12% | 6,000 | $234K | Reduce -40.0% |
| RVMD Revolution Medicines Inc. | 0.12% | 1,200 | $225K | New |
| BBIO Bridgebio Pharma Inc. | 0.12% | 3,000 | $223K | Reduce -50.0% |
| RYTM Rhythm Pharmaceuticals Inc. | 0.12% | 2,000 | $222K | New |
| DNLI Denali Therapeutics Inc. | 0.12% | 8,463 | $218K | New |
| ARWR Arrowhead Pharmaceuticals Inc. | 0.11% | 2,600 | $212K | New |
| SRRK Scholar Rock Holding Corp. | 0.11% | 3,827 | $210K | New |
| EWTX Edgewise Therapeutics Inc. | 0.11% | 5,000 | $203K | Reduce -23.1% |
| AMLX Amylyx Pharmaceuticals Inc. | 0.10% | 10,838 | $195K | No change |
| CTMX Cytomx Therapeutics Inc. | 0.08% | 39,400 | $148K | New |
| OCUL Ocular Therapeutix Inc. | 0.08% | 15,000 | $147K | No change |
| EYPT Eyepoint Inc. | 0.08% | 10,000 | $143K | No change |
| ORIC Oric Pharmaceuticals Inc. | 0.07% | 13,000 | $141K | No change |
| OLMA Olema Pharmaceuticals Inc. | 0.07% | 10,000 | $125K | No change |